CPHI · China Pharma Holdings, Inc.
$1.27
+0.07 (+5.83%)
At close · Jul 30
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Accordingly, substantial doubt is deemed to exist about the Company’s ability to continue as a going concern within one year after the date these financial statements are issued.”View the 10-Q filed May 15, 2026
Market Cap
$52.68M
Shares
40.52M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.20
Open$1.25
Day$1.12–1.27
52W$0.38–19.19
Avg vol 30d8.6M
Short int414K · 1.0% float · 1.0d
Short vol47%
DataJan 2020–Jul 2026
Filing10-Q · May 15
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 15, 2026
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Neutral
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 20.7 · elevated
Equity put/call 0.61
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+13%
above
Price vs 50-day avg
+22%
above
RSI (14)
49
neutral
MACD trend
Negative
52-week position
4%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+82%
trailing
6-month return
+64%
trailing
YTD return
−1%
this year
Relative strength
+58%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
+20% holders QoQ · +2 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
1.02% of float · ▲ +1589.3% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
6 holders — near 1-yr high, broad support
Squeeze score
49
elevated · 0–100
Fundamentals
Revenue growth
−8%
Y/Y
Gross margin
-3%
expanding
EPS growth
+73%
Y/Y
Free cash flow
$88.9K
Balance sheet
$4.9M
net debt
Quant / Vol
risk profile
Volatility
808%
annualized · 1-yr
Max drawdown
−85%
past year
ATR
116.8%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+13%
Bullish
Price vs 50-day avg
+22%
Bullish
RSI (14)
49
Neutral
MACD trend
Negative
Bearish
52-week position
4%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
+20% holders QoQ · +2 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
1.02% of float · ▲ +1589.3% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
6 holders — near 1-yr high, broad support
Price context
position in its 52-week range
52-wk low $0
Now $1 · 4%
52-wk high $19
vs 200-day avg +13%
vs 50-day avg +22%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CPHI
this stock
China Pharma Holdings, Inc.
|
$52.68M | -0.8% | -35.4% | — | 1.0% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$55.09B | +13.9% | — | — | 0.1% |
|
GALDY
Galderma Group AG/ADR
|
$50.38B | +4.2% | — | — | 0.0% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$45.13B | — | — | — | 0.0% |
|
HLN
Haleon plc
|
$44.37B | +1.7% | — | — | 0.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Reducing
Holders
6
- % held
- 0.1%
- Net QoQ
- -3.5K sh
- Top holder
- CITADEL ADVISORS LLC
Held
Float
Short & Settlement
Financials
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CPHI | -29.8% | +81.8% | +64.4% | +81.8% | -0.8% |
| SPY | -2.4% | -2.3% | +6.3% | -2.3% | +7.0% |
| vs SPY | -27.4% | +84.1% | +58.1% | +84.1% | -7.8% |
Key facts
CIK
1106644
CUSIP
16941T401